Immuno-oncology

RSS

Supplemental BLA submitted in U.S. for Proleukin

April 16, 1997

Antitumor activity of Ono-4007 related to TNF induction

April 7, 1997

CAT and Techniclone to initiate trials for tumor therapy

March 27, 1997

Bristol-Myers Squibb discovers new ribosome-inactivating protein

March 27, 1997

Multikine trial approved in Israel

March 21, 1997

Immunogen terminates Oncolysin development

March 20, 1997

Cel-Sci purchases complete rights to Multikine

March 11, 1997

AltaRex receives funding for clinical trials on Ovarex

March 10, 1997

IDEC and Roche submit applications for IDEC-C2B8

March 5, 1997

ONYX expands ONYX-015 clinical trials

March 4, 1997